HOME › Press Releases › Extracorporeal Membrane Oxygenation (ECMO) System Market worth 287.6 Million USD by 2020
Extracorporeal Membrane Oxygenation (ECMO) System Market worth 287.6 Million USD by 2020
The report "Extracorporeal Membrane Oxygenation (ECMO) Systems Market by Modality (Veno -Arterial (VA), Veno -Venous (VV), Arterio-Venous (AV)), by Application (Respiratory, Cardiac, ECPR), by Geography - Global Forecast to 2020", The global extracorporeal membrane oxygenation (ECMO) system report defines and segments the extracorporeal membrane oxygenation (ECMO) system market globally with analysis and forecast of revenue. This market was valued at USD 227.7 Million in 2014, and is expected to reach USD 287.6 Million by 2020, at a CAGR of 4.0% from 2015 to 2020.
Browse 78 market data tables with 91 figures spread through 138 pages and in-depth TOC on "Extracorporeal Membrane Oxygenation (ECMO) Systems Market by Modality (Veno -Arterial (VA), Veno -Venous (VV), Arterio-Venous (AV)), by Application (Respiratory, Cardiac, ECPR), by Geography - Global Forecast to 2020"
Early buyers will receive 10% customization on reports.
The global extracorporeal membrane oxygenation (ECMO) system market is expected to witness substantial growth due to number of surgeries, technological advances, physician’s awareness and patient’s safety.
The global extracorporeal membrane oxygenation (ECMO) system market growth is attributed to the rise in the number of patients suffering from respiratory failure and cardiopulmonary disease, and rising incidence in Chronic Obtrusive Pulmonary Diseases (COPD). Despite this, high cost of devices, risk of complication during ECMO treatment, and presence of conventional techniques are some of the hindering factors.
The ECMO system is a device which is a combination of one membrane oxygenator, cannula, oxygen blender, heat exchanger, post membrane pressure monitor, venous reservoir and centrifugal pump. ECMO transport is an effective method of transferring patients with severe ARDS. It has multiple causes, and the diagnosis should be investigated and treatment commenced during ECMO. Since ECMO is a complicated and high-risk therapy, adequate training in its performance and creation of a referring hospital network are essential.
In 2014, the global extracorporeal membrane oxygenation (ECMO) system market was dominated by North America. This market is segmented and forecast on the basis of modality, application and geography. The modality comprises of Veno Artrial (VA), Veno Venous (VV), Artrio Venous (ECOO2 R). On the basis of application, the market is segmented into respiratory, cardiac, and Extra-Corporeal Cardiopulmonary Resuscitation (ECPR). The market is further segmented and forecast on the basis of major geographies such as North America, Europe, Asia-pacific and rest of the world (RoW).
The market in North America is growing due to improved patient safety and awareness among the doctors and patients for low flow aesthetic agents. The European market is growing due to the technological advancements and is dominated majorly by MAQUET Holding B.V. & CO. KG. (Germany). The Asian market is growing due to increasing adoption rate of ECMO machine in hospitals, success rate of ECMO & government initiatives, and growing awareness towards ECMO.
This report also includes the market share, approach for arriving at the market size, new technology developments, product matrix, life cycle analysis, Porter’s five forces analysis and price analysis by product. In this report, market metrics are also included such as drivers, restraints and upcoming opportunities in the market. In addition, it presents a competitive landscape and company profiles of key players in the market including major companies which provide extracorporeal membrane oxygenation (ECMO) system as a product.
The research study is aimed at identifying emerging trends and opportunities in the global extracorporeal membrane oxygenation (ECMO) system market along with detailed classifications, in terms of revenue. It provides comprehensive competitive landscape and identifies the key players with respect to market size and market share. The research study also includes a detailed segmentation of the global extracorporeal membrane oxygenation (ECMO) system market, on the basis of product, end-user and region.
MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India